Stock listing
NASDAQ:TRBN Trubion Pharmaceuticals Inc Stock
Follow Trubion Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:TRBN
$4.60 USD
Close on Oct 28, 2010 · No longer trades
- Lowest – highest close
- $1.01 – $21.99 USDSince Oct 18, 2006 · lowest Dec 9, 2008 · highest Feb 5, 2007
Delisted NASDAQ:TRBN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:TRBN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Trubion Pharmaceuticals Inc on 6ix
- Decks
- 2 decks · latest Aug 24, 2010
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (August 2010) | Merger or acquisition | 33 slides | Aug 24, 2010 |
| Merger or Acquisition (August 2010) | Merger or acquisition | 14 slides | Aug 19, 2010 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John Bencich Other companies: AEON Biopharma, Inc. (Chief Financial Officer - · Since at least Apr 1, 2026); Achieve Life Sciences, Inc. (CEO, Director · Aug 11, 2014 – Aug 16, 2024 · Past) | V.P. and CFO · Nov 16, 2009 – Oct 28, 2010 · Past |
| Scott Stromatt Other companies: CTi Biopharma Corp (EVP,Clinical Dev & Reg Affair · Jun 20, 2006 – Apr 4, 2008 · Past) | SVP and Chief Medical Officer · Mar 10, 2009 – Oct 28, 2010 · Past |
| Daniel J Burge | Chief Medical Officer, SVP · Mar 12, 2008 – Mar 12, 2008 · Past |
| David A Mann | Director · Oct 17, 2006 – Oct 28, 2010 · Past |
Log in to ask 6ix AI your own questions about Trubion Pharmaceuticals Inc.